Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine

Purpose Pertuzumab and T-DM1 are two efficient anti-HER2 treatments for patients with HER2-positive advanced breast cancer. While pertuzumab is usually given in first-line treatment and T-DM1 in second-line treatment, standard therapy options seem to be exhausted up to now after the treatment of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Laakmann, Elena, Emons, Julius, Taran, Florin-Andrei, Janni, Wolfgang, Uhrig, Sabrina, Overkamp, Friedrich, Kolberg, Hans-Christian, Hadji, Peyman, Tesch, Hans, Häberle, Lothar, Ettl, Johannes, Lüftner, Diana, Wallwiener, Markus, Schulmeyer, Carla, Müller, Volkmar, Beckmann, Matthias W., Belleville, Erik, Wimberger, Pauline, Hielscher, Carsten, Kurbacher, Christian, Wuerstlein, Rachel, Thomssen, Christoph, Untch, Michael, Volz, Bernhard, Fasching, Peter A., Fehm, Tanja N., Wallwiener, Diethelm, Brucker, Sara Y., Schneeweiss, Andreas, Lux, Michael P., Hartkopf, Andreas D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647719/
https://www.ncbi.nlm.nih.gov/pubmed/33173241
http://dx.doi.org/10.1055/a-1286-2917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647719/
https://www.ncbi.nlm.nih.gov/pubmed/33173241
http://dx.doi.org/10.1055/a-1286-2917

Ejemplares similares